Results 231 to 240 of about 56,276 (247)
Some of the next articles are maybe not open access.

Human Monoclonal Antibodies: The Benefits of Humanization

2018
The major reasons for developing human monoclonal antibodies were to be able to efficiently manipulate their effector functions while avoiding immunogenicity seen with rodent antibodies. Those effector functions involve interactions with the complement system and naturally occurring Fc receptors on diverse blood white cells.
openaire   +3 more sources

Human Monoclonal Antibody Technology [PDF]

open access: possible, 1994
The success of Kohler and Milstein (1975) in immortalizing specific antibody secreting cell lines of rodent origin inevitably led to similar attempts to generate human monoclonals. Initially this effort was largely driven by the belief that such products would be clinically (especially therapeutically) superior to their rodent counterparts. In addition
openaire   +1 more source

Production of Human Monoclonal Antibodies

1984
The need to obtain human monoclonal antibodies has not been overshadowed by the immense success of mouse monoclonal antibody technology. Human monoclonal antibodies will be less antigenic for human in vivo studies and therapy; they will be more likely to recognize antigenic subtleties not easily detected by xenogeneic antibodies, and they will have ...
Bradley J. Dyer   +6 more
openaire   +2 more sources

Characterization of Monoclonal Antibodies to Human OC43

1987
Human coronaviruses are important respiratory pathogens (1). These viruses have also been implicated in human neurological diseases (2, 3), and some reports have suggested an association with the demyelinating condition multiple sclerosis (4, 5, 6), although other studies cast doubt upon the role of coronaviruses in this disease (7, 8, 9, 10, 11).
Stephen A. Stohlman   +4 more
openaire   +3 more sources

Fully Human Therapeutic Monoclonal Antibodies

Journal of Immunotherapy, 2006
Monoclonal antibody (mAb) therapy has been facilitated by a number of technologic advances over the past 30 years. Whereas hybridoma development of murine mAbs was requisite for the development of mAbs as drugs, the inherent immunogenicity of rodent sequences in humans has presented obstacles to the clinical application of mAbs.
openaire   +3 more sources

Toward Human Monoclonal Antibodies

1990
OKT3 is a murine monoclonal antibody directed against an epitope on one of the subunits of the CD3 complex on human T cells. CD3 is associated with the T cell receptor and seems to play a role in the expression of the receptor. Clinically it is used as rescue treatment in renal allograft rejection and is currently being tested for use prophylactically ...
Dennis R. Burton   +3 more
openaire   +2 more sources

Monoclonal antibodies in human reproduction

1984
This workshop centred on the effect which monoclonal antibodies (mAbs) are now beginning to make in various fields of research in human reproduction. An introduction by the chairperson, L. Mettler (Kiel, W. Germany), outlined the background to much of the technology involved in the production of mAbs based from the original work of Kohler and Milstein ...
P. M. Johnson, K. Hannon, L. Mettler
openaire   +2 more sources

MONOCLONAL ANTIBODIES TO HUMAN TRANSFERRINS

British Journal of Haematology, 1988
Anne B. Mason   +2 more
openaire   +3 more sources

Monoclonal antibody to human fibronectin

Cell Biology International Reports, 1980
Walsh, F S, Dhut, S
openaire   +2 more sources

Home - About - Disclaimer - Privacy